JP2013544877A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544877A5
JP2013544877A5 JP2013542630A JP2013542630A JP2013544877A5 JP 2013544877 A5 JP2013544877 A5 JP 2013544877A5 JP 2013542630 A JP2013542630 A JP 2013542630A JP 2013542630 A JP2013542630 A JP 2013542630A JP 2013544877 A5 JP2013544877 A5 JP 2013544877A5
Authority
JP
Japan
Prior art keywords
compound
formula
thiadiazol
pyridin
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542630A
Other languages
English (en)
Japanese (ja)
Other versions
JP5851516B2 (ja
JP2013544877A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/050464 external-priority patent/WO2012076989A1/en
Publication of JP2013544877A publication Critical patent/JP2013544877A/ja
Publication of JP2013544877A5 publication Critical patent/JP2013544877A5/ja
Application granted granted Critical
Publication of JP5851516B2 publication Critical patent/JP5851516B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542630A 2010-12-09 2011-02-03 ケトライド化合物 Expired - Fee Related JP5851516B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3352MU2010 2010-12-09
IN3352/MUM/2010 2010-12-09
PCT/IB2011/050464 WO2012076989A1 (en) 2010-12-09 2011-02-03 Ketolide compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015135252A Division JP6102991B2 (ja) 2010-12-09 2015-07-06 ケトライド化合物

Publications (3)

Publication Number Publication Date
JP2013544877A JP2013544877A (ja) 2013-12-19
JP2013544877A5 true JP2013544877A5 (cg-RX-API-DMAC7.html) 2014-03-20
JP5851516B2 JP5851516B2 (ja) 2016-02-03

Family

ID=54259620

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013542630A Expired - Fee Related JP5851516B2 (ja) 2010-12-09 2011-02-03 ケトライド化合物
JP2015135252A Expired - Fee Related JP6102991B2 (ja) 2010-12-09 2015-07-06 ケトライド化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015135252A Expired - Fee Related JP6102991B2 (ja) 2010-12-09 2015-07-06 ケトライド化合物

Country Status (18)

Country Link
US (2) US9175031B2 (cg-RX-API-DMAC7.html)
EP (2) EP2673285B1 (cg-RX-API-DMAC7.html)
JP (2) JP5851516B2 (cg-RX-API-DMAC7.html)
KR (1) KR101657751B1 (cg-RX-API-DMAC7.html)
CN (2) CN103384676B (cg-RX-API-DMAC7.html)
AU (1) AU2011340204B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013014392B1 (cg-RX-API-DMAC7.html)
CA (2) CA2820451C (cg-RX-API-DMAC7.html)
DK (1) DK2673285T3 (cg-RX-API-DMAC7.html)
ES (1) ES2642287T3 (cg-RX-API-DMAC7.html)
HU (1) HUE036658T2 (cg-RX-API-DMAC7.html)
MX (1) MX348084B (cg-RX-API-DMAC7.html)
NZ (1) NZ623574A (cg-RX-API-DMAC7.html)
PL (1) PL2673285T3 (cg-RX-API-DMAC7.html)
PT (1) PT2673285T (cg-RX-API-DMAC7.html)
RU (1) RU2601550C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012076989A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201304150B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587490A (en) * 2010-08-20 2013-03-28 Greentide Ltd Anti-Microbial Compounds containing compounds with a sugar substituent
WO2012127351A1 (en) * 2011-03-22 2012-09-27 Wockhardt Limited Process for preparation of ketolide compounds
US9346828B2 (en) * 2013-06-07 2016-05-24 Wisconsin Alumni Research Foundation Forazolines, compositions thereof and uses thereof
KR101799009B1 (ko) * 2015-07-27 2017-11-17 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 아마이드 유도체 화합물 및 이를 포함하는 약제학적 조성물
RU2697665C1 (ru) 2015-07-27 2019-08-16 Чонг Кун Данг Фармасьютикал Корп. Производные 1,3,4-оксадиазолсульфонамида в качестве ингибиторов деацетилазы гистонов 6 и фармацевтическая композиция, содержащая их
MY194018A (en) 2015-07-27 2022-11-08 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
EP3331864B1 (en) 2015-08-04 2021-11-03 Chong Kun Dang Pharmaceutical Corp. 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
AU2016338118B2 (en) 2015-10-12 2019-03-14 Chong Kun Dang Pharmaceutical Corp. Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
AU2017206671A1 (en) * 2016-01-12 2018-08-23 Wockhardt Limited Pharmaceutical compositions for the treatment of bacterial infections
WO2017122127A1 (en) * 2016-01-12 2017-07-20 Wockhardt Limited Pharmaceutical compositions
US10857171B2 (en) * 2016-01-12 2020-12-08 Wockhardt Limited Pharmaceutical compositions
JP6887022B2 (ja) * 2017-03-16 2021-06-16 ウォックハート リミテッド ケトライド化合物を製造するための方法
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
JP7451569B2 (ja) 2019-05-31 2024-03-18 チョン クン ダン ファーマシューティカル コーポレーション ヒストン脱アセチル化酵素6阻害剤としての1,3,4-オキサジアゾールホモフタルイミド誘導体化合物、およびそれを含む薬剤学的組成物
JP7712922B2 (ja) 2019-11-05 2025-07-24 デルミラ インコーポレイテッド 炎症性障害を治療するためのMrgprX2アンタゴニスト
US20230002336A1 (en) * 2019-11-05 2023-01-05 Dermira, Inc. MrgprX2 Antagonists and Uses Thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DK1291351T3 (da) 1996-09-04 2005-10-24 Abbott Lab 6-O-substituerede ketolider med antibakteriel aktivitet
WO1999021870A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
KR100502031B1 (ko) 2000-08-22 2005-07-25 바실리어 파마슈티카 아게 항균 활성을 갖는 신규한 매크롤라이드
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
CN1492874A (zh) 2000-12-21 2004-04-28 大环内酯
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
CN101541331A (zh) * 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
US20090075915A1 (en) * 2007-09-17 2009-03-19 In Jong Kim 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
EP2435460B1 (en) * 2009-05-27 2015-01-07 Wockhardt Limited Ketolide compounds having antimicrobial activity

Similar Documents

Publication Publication Date Title
JP2013544877A5 (cg-RX-API-DMAC7.html)
RU2013131234A (ru) Кетолидные соединения
US9926285B2 (en) Allosteric modulators of nicotinic acetylcholine receptors
JP5728487B2 (ja) 三環式ヘテロ環化合物
US10047083B2 (en) Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
UA122385C2 (uk) Сульфамоїлариламіди та їх застосування як лікарських препаратів для лікування гепатиту b
US20230382889A1 (en) Compounds for inhibiting kif18a
US7432293B2 (en) Heterocyclic compounds useful as Nurr-1 activators
JP2014532626A5 (cg-RX-API-DMAC7.html)
JP2010523643A5 (cg-RX-API-DMAC7.html)
EP1446403B1 (en) Aryl substituted oxazolidinones with antibacterial activity
JP2003515607A (ja) 置換イソオキサゾリン類及びその抗菌剤としての使用
WO2013018735A1 (ja) アミジン化合物又はその塩
US20180127407A1 (en) Benzothiazole Or Benzoxazole Compounds As Sumo Activators
JP2017511368A5 (cg-RX-API-DMAC7.html)
US7326790B2 (en) Diphenylisoxazole compounds and hydro isomers thereof
CN101142183A (zh) 有丝分裂驱动蛋白抑制剂
CN107540624B (zh) 热休克蛋白抑制剂及其制备方法和应用
KR101169359B1 (ko) 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
RU2006140998A (ru) Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии
EP2445892A1 (en) 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
JP2017165653A (ja) アゾールカルボン酸誘導体
JP2007517855A5 (cg-RX-API-DMAC7.html)
CN118878535A (zh) 取代的吡啶并三氮唑化合物及其制备方法和用途
BR112019010571B1 (pt) Compostos, inibidor de pde4 e composição farmacêutica que os compreende